Prediction of Congenital Malformations in The Fetus Based on The Carriage of Single Nucleotide Variants of Folate Cycle Genes by a Mother with Epilepsy
https://doi.org/10.52667/2712-9179-2024-5-2-19-25
Abstract
The prediction and prevention of congenital malformations in the fetus of women with epilepsy is an urgent problem due to the need for long-term use of antiepileptic drugs. The aim was to study the frequency of carriage of single-nucleotide variants (SNVs) rs1801133 and rs1801131 of the MTHFR gene; rs1801394 of the MTRR gene, rs1805087 of the MTR gene and rs1051266 of the SLC19A1 gene in women with epilepsy and to evaluate their associations with congenital malformations of the fetus (CMF). Materials and methods. The study included 61 patients with epilepsy who had a history of one or more pregnancies with a known outcome due to the presence of CMF in the child. The patients were divided into two groups: 20 patients had various CMF (the main group), 41 patients had children who were born without CMF (the comparison group). DNA was isolated from the blood, and genotyping of five DNA sequences in four genes was performed by polymerase chain reaction. The frequencies of genotypes and alleles in the mothers of the main group and the comparison group were determined, the differences were assessed using Pearson's chi-square criterion (χ2) and Fisher's exact criterion. Results. There were no statistically significant differences in the frequencies of genotypes and alleles for all analyzed SNVs between the main group and the comparison group (p > 0.05). There were no statistically significant differences in the frequencies of genotypes and alleles of SNVs of the studied genes in mothers of children with CMF (n = 14) and without CMF (n = 22) taking valproic acid (p > 0.05). A statistically significant relationship has been revealed between the carrier of a certain haplogroup of the mother and the formation of CMF. Conclusion. The development of VPD in a child is a multifactorial phenomenon in which genetic factors with a small effect size can play a role only in the case of certain unfavorable combinations.
About the Authors
Albina V. Yakunina
Samara State Medical University
Russian Federation
Russian Federation
443099 Samara.
Anastasiya S. Chesnokova
Samara State Medical University
Russian Federation
Russian Federation
443099 Samara.
Natalia N. Savelieva
Samara State Medical University
Russian Federation
Russian Federation
443099 Samara.
References
1. Meador K.J. Effects of maternal use of antiseizure medications on child development. Neurol Clin. 2022;40(4):755-768. doi: 10.1016/j.ncl.2022.03.006
2. Holmes L.B., Quinn M., Conant S., et al. Ascertainment of malformations in pregnancy registries: Lessons learned in the North American AED Pregnancy Registry. Birth Defects Res. 2023;115(14):1274-1283. doi: 10.1002/bdr2.2188
3. Laganа A.S., Triolo O., D'Amico V., et al. Management of women with epilepsy: from preconception to post-partum. Arch Gynecol Obstet. 2016;293(3):493-503. doi: 10.1007/s00404-015-3968-7
4. Dmitrenko D.V., Shnayder N.A., Egorova A.T. Epilepsy and pregnancy. Moscow, 2014. (In Russ.). ISBN 978-5-98495-025-1
5. Keni R.R., Jose M., Sarma P.S., Thomas S.V. Kerala Registry of Epilepsy and Pregnancy Study Group. Teratogen-icity of antiepileptic dual therapy: Dose-dependent, drug-specific, or both? Neurology. 2018;90(9):e790-e796. doi: 10.1212/WNL.0000000000005031
6. Cohen J.M., Alvestad S., Cesta C.E., et al. Comparative safety of antiseizure medication monotherapy for major malformations. Ann Neurol. 2023;93(3):551-562. doi: 10.1002/ana.26561
7. Shengelia М.O., Bespalova O.N., Shengelia N.D., et al. Folate-dependent congenital malformations of the fetus. Womens health and reproduction. 2022;1(52):49-57. (In Russ.).
8. Sijilmassi O., Del Río Sevilla A., Maldonado Bautista E., Barrio Asensio M.D.C. Gestational folic acid deficiency alters embryonic eye development: Possible role of basement membrane proteins in eye malformations. Nutrition. 2021;90:111250. doi: 10.1016/j.nut.2021.111250
9. Almekkawi A.K., Al Jardali M.W., Daadaa H.M., et al. Folate pathway gene single nucleotide polymorphisms and neural tube defects: A systematic review and meta-analysis. J Pers Med. 2022;12(10):1609. doi: 10.3390/jpm12101609
10. Liew S.C., Gupta E.D. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, me-tabolism and the associated diseases. European Journal of Medical Genetics. 2015;58(1):1-10. doi: 10.1016/j.ejmg.2014.10.004
11. Taiwo E.T., Cao X., Cabrera R.M., et al. Approaches to studying the genomic architecture of complex birth de-fects. Prenat Diagn. 2020;40(9):1047-1055. doi: 10.1002/pd.5760
12. Dewelle W.K., Melka D.S., Aklilu A.T., et al. Polymorphisms in maternal selected folate metabolism-related genes in neural tube defect-affected pregnancy. Adv Biomed Res. 2023;12:160. doi: 10.4103/abr.abr_103_22
13. Godbole K., Gayathri P., Ghule S., et al. Maternal one-carbon metabolism, MTHFR and TCN2 genotypes and neural tube defects in India. Birth Defects Res A Clin Mol Teratol. 2011;91:848–56. doi: 10.1002/bdra.20841
14. Ouyang S., Li Y., Liu Z., et al. Association between MTR A2756G and MTRR A66G polymorphisms and maternal risk for neural tube defects: A meta-analysis. Gene. 2013;515:308–12. doi: 10.1016/j.gene.2012.11.070
15. Dmitrenko D.V., Shnayder N.A., Strotskaya I.G., et al. Mechanisms of valproate-induced teratogenesis. Neurolo-gy, Neuropsychiatry, Psychosomatics. 2017;1S:89–96. doi: 10.14412/2074-2711-2017-1S-89-96
16. Shnayder N.A., Grechkina V.V., Khasanova A.K., et al. Therapeutic and toxic effects of valproic acid metabolites. Metabolites. 2023;13(1):134. doi: 10.3390/metabo13010134
17. Shnayder N.A., Grechkina V.V., Trefilova VV, et al. Valproate-induced metabolic syndrome. Biomedicines. 2023;11(5):1499. doi: 10.3390/biomedicines11051499
18. Boyle E.A., Li Y.I., Pritchard J.K. An expanded view of complex traits: from polygenic to omnigenic. Cell. 2017;169(7):1177–1186. doi: 10.1016/j.cell.2017.05.038
19. Finnell R.H., Caiaffa C.D., Kim S.E., et al. Gene environment interactions in the etiology of neural tube defects. Front Genet. 2021;10;12:659612. doi: 10.3389/fgene.2021.659612
20. Choi S.W., Mak T.S., O'Reilly P.F. Tutorial: a guide to performing polygenic risk score analyses. Nat. Protoc. 2020;15(9):2759–2772. doi: 10.1038/s41596-020-0353-1
Review
For citations:
Yakunina A.V., Chesnokova A.S., Savelieva N.N. Prediction of Congenital Malformations in The Fetus Based on The Carriage of Single Nucleotide Variants of Folate Cycle Genes by a Mother with Epilepsy. Personalized Psychiatry and Neurology. 2025;5(2):19-25. https://doi.org/10.52667/2712-9179-2024-5-2-19-25
Views:
43
Email this article 